Show simple item record

dc.contributor.authorGlebov, Konstantin
dc.contributor.authorWunderlich, P
dc.contributor.authorKaraca, I
dc.contributor.authorWalter, J
dc.date.accessioned2019-01-30T12:49:21Z
dc.date.available2019-01-30T12:49:21Z
dc.date.issued2016-12
dc.identifier.issn1742-2094
dc.identifier.issn1742-2094
dc.identifier.other17
dc.identifier.urihttp://hdl.handle.net/10026.1/13239
dc.description.abstract

BACKGROUND: Triggering receptor expressed on myeloid cells-2 (TREM2) exerts important functions in the regulation of monocytes, like dendritic cells, osteoclasts, tissue macrophages, and microglia. Mutations in TREM2 are associated with several diseases, including Nasu-Hakola disease, frontotemporal dementia, and Alzheimer's disease (AD). TREM2 undergoes sequential proteolytic processing by ectodomain shedding and intramembrane proteolysis. FINDINGS: We show that inhibition of γ-secretase-dependent cleavage of the TREM2 C-terminal fragment in cellular membranes interferes with TREM2-dependent signaling and cellular function. Inhibition of γ-secretase decreases membrane-proximal signaling and intracellular Ca(2+) response. Decreased signaling alters morphological changes and phagocytic activity of cells upon selective stimulation of TREM2. CONCLUSIONS: The data demonstrate the importance of γ-secretase-dependent intramembrane processing in TREM2-mediated signaling and, thus, a functional relation of two AD-associated proteins.

dc.format.extent17-
dc.format.mediumElectronic
dc.languageen
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.subjectTriggering receptor expressed on myeloid cells-2
dc.subjectTREM2
dc.subjectgamma-Secretase
dc.subjectPresenilin
dc.subjectReceptor shedding
dc.subjectPhosphatidylinositol-4,5-bisphosphate
dc.subjectIntracellular Ca2+
dc.subjectPhagocytosis
dc.titleFunctional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2)
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368417900003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue1
plymouth.volume13
plymouth.publication-statusPublished
plymouth.journalJournal of Neuroinflammation
dc.identifier.doi10.1186/s12974-016-0479-9
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeEngland
dcterms.dateAccepted2016-01-11
dc.identifier.eissn1742-2094
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1186/s12974-016-0479-9
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-01-20
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV